The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results.
The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results. Chin Clin Oncol. 2021 Aug; 10(4):38.